Urology Associates of Central California | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer	Intermediate Risk Non-Muscle Invasive Bladder Cancer	Recruiting	Phase 3	2026-10-07		NCT06510374
Post-Market Study to Assess iTind Safety in Comparison to UroLift	Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder	Recruiting	Not applicable	2026-09-29		NCT04757116
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC	Metastatic Castrate-sensitive Prostate Cancer	Active, not recruiting	Phase 3	2026-09-25		NCT05884398
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not stated	2026-09-15		NCT05712473
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer	prostate adenocarcinoma	Recruiting	Phase 1	2026-08-11		NCT06257693
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Not applicable	2026-07-02		NCT06394869